Inhibition of PI3K increases oxaliplatin sensitivity in cholangiocarcinoma cells
<p>Abstract</p> <p>Background</p> <p>Resistance of cholangiocarcinoma to chemotherapy is a major problem in cancer treatment. The mechanism of resistance is believed to involve phosphoinositide-3- kinase (PI3K)/Akt activation. Although the platinum-containing compound o...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2009-01-01
|
| Series: | Cancer Cell International |
| Online Access: | http://www.cancerci.com/content/9/1/3 |